Amr Abdulazim1, Carla Küppers2, Katharina A M Hackenberg2, Eva Neumaier-Probst3, Mohamad Mansour Alzghloul3, Jörg Krebs4, Manfred Thiel4, Hester Lingsma5, Gabriel J E Rinkel2, Christoph Groden3, Nima Etminan2. 1. Department of Neurosurgery, University Hospital Mannheim, Medical Faculty Mannheim, University of Heidelberg, Theodor-Kutzer-Ufer 1-3, 68167, Mannheim, Germany. amr.abdulazim@umm.de. 2. Department of Neurosurgery, University Hospital Mannheim, Medical Faculty Mannheim, University of Heidelberg, Theodor-Kutzer-Ufer 1-3, 68167, Mannheim, Germany. 3. Department of Neuroradiology, University Hospital Mannheim, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany. 4. Department of Anaesthesiology and Critical Care Medicine, University Hospital Mannheim, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany. 5. Center for Medical Decision Sciences, Erasmus MC-University Medical Center Rotterdam, Rotterdam, the Netherlands.
Abstract
BACKGROUND: The appropriate management of delayed cerebral ischemia (DCI) after aneurysmal subarachnoid hemorrhage (aSAH) remains uncertain. We aimed to evaluate the effect of implementing a standardized protocol for detection and management of DCI after aSAH on cerebral infarction and functional outcome. METHODS: We studied two cohorts of aSAH patients, one before (pre-implementation cohort: January 2012 to August 2014) and one after (post-implementation cohort: January 2016 to July 2018) implementation of a multidisciplinary approach, with standardized neurological and radiological assessment and risk-based medical treatment of DCI. We assessed the presence of new hypodensities on CT within 6 weeks after aSAH and categorized cerebral infarction into overall and DCI-related infarctions (hypodensities not within 48 h after IA repair and not attributable to aneurysm occlusion or intraparenchymal hematoma). Functional outcome was assessed at 3 months using the extended Glasgow outcome scale (eGOS), dichotomized into unfavorable (eGOS: 1-5) and favorable (eGOS: 6-8). We calculated odds ratios (OR) with corresponding 95% confidence intervals (CI's), and adjusted for age, WFNS grade, Fisher score, and treatment modality (aOR). RESULTS: In the post-implementation (n = 158) versus the pre-implementation (n = 143) cohort the rates for overall cerebral infarction were 29.1% vs 46.9% (aOR: 0.41 [0.24-0.69]), for DCI-related cerebral infarction 17.7% vs. 31.5% (aOR: 0.41 [0.23-0.76]), and for unfavorable functional outcome at 3 months 37.3% vs. 53.8% (aOR: 0.30 [0.17-0.54]). For patients with DCI, the rates for unfavorable functional outcomes at 3 months in the post-implementation versus the pre-implementation cohort were 42.3% vs. 77.8% (aOR: 0.1 [0.03-0.27]). CONCLUSIONS: A multidisciplinary approach with more frequent and standardized neurological assessment, standardized CT and CT perfusion monitoring, as well as tailored application of induced hypertension and invasive rescue therapy strategies, is associated with a significant reduction of cerebral infarction and unfavorable functional outcome after aneurysmal aSAH.
BACKGROUND: The appropriate management of delayed cerebral ischemia (DCI) after aneurysmal subarachnoid hemorrhage (aSAH) remains uncertain. We aimed to evaluate the effect of implementing a standardized protocol for detection and management of DCI after aSAH on cerebral infarction and functional outcome. METHODS: We studied two cohorts of aSAH patients, one before (pre-implementation cohort: January 2012 to August 2014) and one after (post-implementation cohort: January 2016 to July 2018) implementation of a multidisciplinary approach, with standardized neurological and radiological assessment and risk-based medical treatment of DCI. We assessed the presence of new hypodensities on CT within 6 weeks after aSAH and categorized cerebral infarction into overall and DCI-related infarctions (hypodensities not within 48 h after IA repair and not attributable to aneurysm occlusion or intraparenchymal hematoma). Functional outcome was assessed at 3 months using the extended Glasgow outcome scale (eGOS), dichotomized into unfavorable (eGOS: 1-5) and favorable (eGOS: 6-8). We calculated odds ratios (OR) with corresponding 95% confidence intervals (CI's), and adjusted for age, WFNS grade, Fisher score, and treatment modality (aOR). RESULTS: In the post-implementation (n = 158) versus the pre-implementation (n = 143) cohort the rates for overall cerebral infarction were 29.1% vs 46.9% (aOR: 0.41 [0.24-0.69]), for DCI-related cerebral infarction 17.7% vs. 31.5% (aOR: 0.41 [0.23-0.76]), and for unfavorable functional outcome at 3 months 37.3% vs. 53.8% (aOR: 0.30 [0.17-0.54]). For patients with DCI, the rates for unfavorable functional outcomes at 3 months in the post-implementation versus the pre-implementation cohort were 42.3% vs. 77.8% (aOR: 0.1 [0.03-0.27]). CONCLUSIONS: A multidisciplinary approach with more frequent and standardized neurological assessment, standardized CT and CT perfusion monitoring, as well as tailored application of induced hypertension and invasive rescue therapy strategies, is associated with a significant reduction of cerebral infarction and unfavorable functional outcome after aneurysmal aSAH.
Authors: Andrew P Carlson; Daniel Hänggi; George K Wong; Nima Etminan; Stephan A Mayer; François Aldrich; Michael N Diringer; Erich Schmutzhard; Herbert J Faleck; David Ng; Benjamin R Saville; Thomas Bleck; Robert Grubb; Michael Miller; Jose I Suarez; Howard M Proskin; R Loch Macdonald Journal: Stroke Date: 2020-03-06 Impact factor: 7.914
Authors: Charlotte H P Cremers; Irene C van der Schaaf; Emerens Wensink; Jacoba P Greving; Gabriel J E Rinkel; Birgitta K Velthuis; Mervyn D I Vergouwen Journal: J Cereb Blood Flow Metab Date: 2013-11-27 Impact factor: 6.200
Authors: N Marlou Haegens; Celine S Gathier; Janneke Horn; Bert A Coert; Dagmar Verbaan; Walter M van den Bergh Journal: Stroke Date: 2018-11 Impact factor: 7.914
Authors: Celine S Gathier; Walter M van den Bergh; Mathieu van der Jagt; Bon H Verweij; Jan Willem Dankbaar; Marcella C Müller; Annemarie W Oldenbeuving; Gabriel J E Rinkel; Arjen J C Slooter Journal: Stroke Date: 2017-11-20 Impact factor: 7.914
Authors: Charlotte H P Cremers; Pieter C Vos; Irene C van der Schaaf; Birgitta K Velthuis; Mervyn D I Vergouwen; Gabriel J E Rinkel; Jan Willem Dankbaar Journal: Neuroradiology Date: 2015-06-02 Impact factor: 2.804
Authors: Airton Leonardo de Oliveira Manoel; Alberto Goffi; Tom R Marotta; Tom A Schweizer; Simon Abrahamson; R Loch Macdonald Journal: Crit Care Date: 2016-01-23 Impact factor: 9.097